LB2302. Ceftobiprole Compared to Daptomycin With or Without Optional Aztreonam for the Treatment of Complicated Staphylococcus aureus (SAB): Results of a Phase 3, Randomized, Double-Blind Trial (ERADICATE).

Thomas L Holland, Sara E Cosgrove, Sarah B Doernberg, Oleksander Pavlov, Ivan Titov, Boyko Atanasov, Maziar Assadi Gehr, Marc Engelhardt, Kamal Hamed, Daniel Ionescu, Mark Jones, Mikael Sauley, Jennifer Smart, Harald Seifert, Timothy C Jenkins, Nicholas A Turner, Vance G Fowler. LB2302. Ceftobiprole Compared to Daptomycin With or Without Optional Aztreonam for the Treatment of Complicated Staphylococcus aureus (SAB): Results of a Phase 3, Randomized, Double-Blind Trial (ERADICATE). Open Forum Infectious Diseases. 2022 Dec 15; 9(Suppl 2):ofac492.1892.

2022
https://researcherprofiles.org/profile/368859440

Thomas L Holland, Sara E Cosgrove, Sarah B Doernberg, Oleksander Pavlov, Ivan Titov, Boyko Atanasov, Maziar Assadi Gehr, Marc Engelhardt, Kamal Hamed, Daniel Ionescu, Mark Jones, Mikael Sauley, Jennifer Smart, Harald Seifert, Timothy C Jenkins, Nicholas A Turner, Vance G Fowler